My guess is they will continue to call it 18 month, etc. because it's the same set of patients with some (super-6 +) continuing on the same dose perhaps. Some might call usage of "18-month" a bit misleading but I'm not complaining.
No. Do not expect anything as it is not forthcoming. What is forthcoming is dilution and rights issues for management as they are Hard Working. I could give 23 people a pill every day and report nothing and vote myself pay increases etc. Novice investors, protect yourself at all times with STOP LOSSES. This is likely to have a sequence of down days this week which will leave longs reeling and wondering just what it was that hit them.
News 
Market Data 
Discover 
AI
